Results 101 to 110 of about 1,129,922 (280)
Editorial: Supramolecular Chirogenesis in Chemical and Related Sciences
Yue Sun +5 more
doaj +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Equity and Inclusion in the Chemical Sciences Requires Actions not Just Words. [PDF]
Sanford MS.
europepmc +1 more source
The article “Multiple Chemical Sensitivity: A Clinical Perspective”, published in Brain Sciences, suggests that multiple chemical sensitivity (MCS) is primarily a psychogenic disorder, rooted in unresolved emotional trauma and stress responses [...]
Elaine Psaradellis
doaj +1 more source
Accelerated chemical science with AI
The ASLLA Symposium focused on accelerating chemical science with AI. Discussions on data, new applications, algorithms, and education were summarized. Recommendations for researchers, educators, and academic bodies were provided.
Seoin Back +20 more
openaire +3 more sources
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Flow Chemistry in Contemporary Chemical Sciences: A Real Variety of Its Applications. [PDF]
Trojanowicz M.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source

